Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2015 Dec 16;7(1):1-3.
doi: 10.1007/s13340-015-0246-7. eCollection 2016 Mar.

Diabetic nephropathy and transcription factors

Yuichi Makino  1 , Masakazu Haneda  1
Affiliations
Editorial

Diabetic nephropathy and transcription factors

Yuichi Makino et al. Diabetol Int. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

M. Haneda received lecture fees from Boehringer Ingelheim GmbH, Mitsubishi Tanabe Pharma Corporation, Novo Nordisk Pharma Ltd., Taisho Pharmaceutical Co., Ltd., Sanofi K.K., Astellas Pharma Inc., Kowa Pharmaceutical Co., Ltd., Novartis Pharma K.K., AstraZeneca K.K., Ono Pharmaceutical Co., Ltd., and Taisho Toyama Pharmaceutical Co., Ltd. M. Haneda received research grants from Boehringer Ingelheim GmbH, Mitsubishi Tanabe Pharma Corporation, Novo Nordisk Pharma Ltd., Taisho Pharmaceutical Co., Ltd., Sanofi K.K., Astellas Pharma Inc., Kowa Pharmaceutical Co., Ltd., Novartis Pharma K.K., AstraZeneca K.K., Ono Pharmaceutical Co., Ltd., Taisho Toyama Pharmaceutical Co., Ltd., Eli Lilly and Co., Kissei Pharmaceutical Co. Ltd., Takeda Pharmaceutical Co. Ltd., Shionogi & Co. Ltd., and Daiichi Sankyo Co. Ltd. Y. Makino declares that he has no conflict of interest.This article does not report any studies with human or animal subjects that were performed by any of the authors.

References

    1. Gnudi L, Viberti G, Raij L, et al. GLUT-1 overexpression: link between hemodynamic and metabolic factors in glomerular injury? Hypertension. 2003;42:19–24. doi: 10.1161/01.HYP.0000075949.19968.EF. - DOI - PubMed
    1. Mueller PW, Rogus JJ, Cleary PA, et al. Genetics of kidneys in diabetes (GoKinD) study: a genetics collection available for identifying genetic susceptibility factors for diabetic nephropathy in type 1 diabetes. J Am Soc Nephrol. 2006;17:1782–1790. doi: 10.1681/ASN.2005080822. - DOI - PMC - PubMed
    1. Mason RM, Wahab NA. Extracellular matrix metabolism in diabetic nephropathy. J Am Soc Nephrol. 2003;14:1358–1373. doi: 10.1097/01.ASN.0000065640.77499.D7. - DOI - PubMed
    1. Maezawa Y, Takemoto M, Yokote K. Cell biology of diabetic nephropathy: roles of endothelial cells, tubulointerstitial cells and podocytes. J Diabetes Investig. 2015;6:3–15. doi: 10.1111/jdi.12255. - DOI - PMC - PubMed
    1. Haneda M, Koya D, Kikkawa R. Cellular mechanisms in the development and progression of diabetic nephropathy: activation of the DAG-PKC-ERK pathway. Am J Kidney Dis. 2001;38(4 Suppl 1):S178–S181. doi: 10.1053/ajkd.2001.27438. - DOI - PubMed

Publication types

LinkOut - more resources